Safety Experience with a Monocomponent Acellular Pertussis Vaccine:No Reported Hypotonic-Hyporesponsive Episodes in >50,000 Infants † 921
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details